Monthly
US$200
Billed every month
Potassium Chloride Injection(氯化钾注射液)
Companies, stages and changes, with each record available on this page.
Last 90 days: Marketing application approved: 1 applicationAccepted: 2 applicationsNo longer listed under review: 1 application
Current coverage may be incomplete
Which companies are listed, and at what stages?
Each source is counted separately. Expand a list to inspect companies, identifiers, dates and sources.
Company names, approval identifiers and strengths are retained as recorded in the Chinese sources. Category labels include the original wording for verification.
Catalogue holders45View records ↓
Under-review filings10View records ↓
This year’s generic filers2View records ↓
NHSA approval numbers125View records ↓
API companies with A status13View records ↓
Chemical-drug catalogue
Loaded records: 45 holders; 21 in the quality-and-efficacy consistency-evaluation category, and 24 in the new chemical-registration-classification generic category. Category counts may overlap.
| Marketing authorization holder | Manufacturer | Approval number | Approved | Strength / specification | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| 山西普恒制药有限公司 | 山西诺成制药有限公司 | 国药准字H20265613 | 2026/08/04 | 10ml：1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 沈药合泽药业（山东）有限公司 | 广东星昊药业有限公司 | 国药准字H20265219 | 2026/07/21 | 10ml:1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 江苏华阳制药有限公司 | 江苏华阳制药有限公司 | 国药准字H20263958 | 2026/04/14 | 10ml∶1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 绪必迪药业（河北）有限公司 | 上海浦津林州制药有限公司 | 国药准字H20263803 | 2026/03/31 | 10ml：1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 上海浦津林州制药有限公司 | 上海浦津林州制药有限公司 | 国药准字H20269075 | 2026/03/26 | 10ml：1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 扬州中宝药业股份有限公司 | 扬州中宝药业股份有限公司 | 国药准字H20227042 | 2025/11/14 | 10ml：1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 福州基石医药科技有限公司 | 湖北科伦药业有限公司 | 国药准字H20255870 | 2025/11/04 | 10ml：1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 湖北一半天制药有限公司 | 湖北科伦药业有限公司 | 国药准字H20258217 | 2025/09/28 | 10ml:1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 江西博泰药业有限公司 | 江西东抚制药有限公司 | 国药准字H20255458 | 2025/09/09 | 10ml:1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 安徽双鹤药业有限责任公司 | 安徽双鹤药业有限责任公司 | 国药准字H20258168 | 2025/08/25 | 10ml：1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 广州瑞尔医药科技有限公司 | 广东星昊药业有限公司 | 国药准字H20254516 | 2025/06/10 | 10ml∶1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 重庆万霖生物医药科技有限公司 | 江苏大红鹰恒顺药业有限公司 | 国药准字H20254498 | 2025/06/10 | 10ml:1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 海南欧若拉生物技术有限公司 | 江苏大红鹰恒顺药业有限公司 | 国药准字H20254386 | 2025/05/27 | 10ml：1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 国药集团容生制药有限公司 | 国药集团容生制药有限公司 | 国药准字H20217128 | 2025/04/25 | 10ml：1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 南京赛瑞谱顿制药有限公司 | 江苏大红鹰恒顺药业有限公司 | 国药准字H20253715 | 2025/03/25 | 10ml：1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 海南景泽康生物科技有限公司 | 广东星昊药业有限公司 | 国药准字H20253722 | 2025/03/25 | 10ml：1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 华夏生生药业（北京）有限公司 | 华夏生生药业（北京）有限公司 | 国药准字H20253540 | 2025/03/04 | 10ml：1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广东科泓药业有限公司 | 河南科伦药业有限公司 | 国药准字H20253561 | 2025/03/04 | 20ml：3g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广东科泓药业有限公司 | 河南科伦药业有限公司 | 国药准字H20253560 | 2025/03/04 | 10ml：1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 北京布霖生物科技有限公司 | 华夏生生药业（北京）有限公司 | 国药准字H20253478 | 2025/02/25 | 10ml∶1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 遂成药业股份有限公司 | 遂成药业股份有限公司 | 国药准字H20247306 | 2024/12/05 | 20ml：3.0g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 遂成药业股份有限公司 | 遂成药业股份有限公司 | 国药准字H20247305 | 2024/12/05 | 10ml：1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 津药和平（天津）制药有限公司 | 津药和平（天津）制药有限公司 | 国药准字H12020517 | 2024/12/04 | 10ml：1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 成都欣捷高新技术开发股份有限公司 | 山东华鲁制药有限公司 | 国药准字H20249480 | 2024/12/01 | 10ml∶1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 黑龙江博宇制药有限公司 | 湖北科伦药业有限公司 | 国药准字H20249675 | 2024/12/01 | 10ml：1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河南群益医药科技开发有限公司 | 山东华鲁制药有限公司 | 国药准字H20249638 | 2024/12/01 | 10ml：1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都米子生物医药科技有限公司 | 山东华鲁制药有限公司 | 国药准字H20249481 | 2024/12/01 | 10ml∶1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 南京恩泰医药科技有限公司 | 江苏大红鹰恒顺药业有限公司 | 国药准字H20249553 | 2024/12/01 | 10ml：1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石药银湖制药有限公司 | 石药银湖制药有限公司 | 国药准字H20227117 | 2024/11/29 | 10ml：1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 华润双鹤利民药业（济南）有限公司 | 华润双鹤利民药业（济南）有限公司 | 国药准字H20247294 | 2024/11/27 | 10ml:1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 湖北津药药业股份有限公司 | 湖北津药药业股份有限公司 | 国药准字H20247289 | 2024/11/20 | 10ml：1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 四川美大康华康药业有限公司 | 山东华鲁制药有限公司 | 国药准字H20247278 | 2024/11/07 | 10ml∶1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 成都倍特药业股份有限公司 | 海南倍特药业有限公司 | 国药准字H20247231 | 2024/09/30 | 10ml: 1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 中国大冢制药有限公司 | 中国大冢制药有限公司 | 国药准字H20053711 | 2024/09/25 | 10ml：1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 重庆药谷制药有限公司 | 哈尔滨三联药业股份有限公司 | 国药准字H20244355 | 2024/06/28 | 20ml∶3.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 重庆药谷制药有限公司 | 哈尔滨三联药业股份有限公司 | 国药准字H20244356 | 2024/06/28 | 10ml∶1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 河北天成药业股份有限公司 | 河北天成药业股份有限公司 | 国药准字H20184082 | 2024/06/13 | 10ml:1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 河北天成药业股份有限公司 | 河北天成药业股份有限公司 | 国药准字H20247130 | 2024/06/13 | 20ml：3.0g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山西诺成制药有限公司 | 山西诺成制药有限公司 | 国药准字H20173187 | 2024/06/12 | 10ml:1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山东华鲁制药有限公司 | 山东华鲁制药有限公司 | 国药准字H20184029 | 2024/05/07 | 10ml∶1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山东华鲁制药有限公司 | 山东华鲁制药有限公司 | 国药准字H20247092 | 2024/05/07 | 20ml∶3.0g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 山东齐都药业有限公司 | 山东齐都药业有限公司 | 国药准字H20237084 | 2024/04/15 | 10ml∶1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 哈尔滨三联药业股份有限公司 | 哈尔滨三联药业股份有限公司 | 国药准字H20084537 | 2024/03/28 | 10ml∶1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 海南紫程众投生物科技有限公司 | 天津金耀药业有限公司 | 国药准字H20243188 | 2024/02/20 | 10ml：1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广州艾奇西医药科技有限公司 | 河北天成药业股份有限公司 | 国药准字H20243140 | 2024/02/06 | 10 ml：1.5 g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广州艾奇西医药科技有限公司 | 河北天成药业股份有限公司 | 国药准字H20243139 | 2024/02/06 | 20 ml：3.0 g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 石家庄四药有限公司 | 石家庄四药有限公司 | 国药准字H20247013 | 2024/01/16 | 20ml: 3.0g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 石家庄四药有限公司 | 石家庄四药有限公司 | 国药准字H20183142 | 2023/11/02 | 10ml:1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 湖北科伦药业有限公司 | 湖北科伦药业有限公司 | 国药准字H42021164 | 2023/07/19 | 10ml:1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 辰欣药业股份有限公司 | 辰欣药业股份有限公司 | 国药准字H20184024 | 2023/05/04 | 10ml：1.5g | Drug that passed quality-and-efficacy consistency evaluation (通过质量和疗效一致性评价的药品) | CDE |
| 江西博泰药业有限公司 | 江西东抚制药有限公司 | 国药准字H20255459 | 2025/09/09 | 20ml:3.0g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 成都华宇制药有限公司 | 成都华宇制药有限公司 | 国药准字H20254317 | 2025/05/27 | 10ml∶1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
| 广州合和医药有限公司 | 广东星昊药业有限公司 | 国药准字H20254263 | 2025/05/27 | 10ml︰1.5g | Generic approved under the new chemical-drug registration classification (按化学药品新注册分类批准的仿制药) | CDE |
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
NHSA drug codes
Loaded records: 125 distinct approval numbers and 93 companies.
| Company / applicant | Approval number | Strength / specification | NHSA class | NHSA drug code | View source |
|---|---|---|---|---|---|
| 北京益民药业有限公司 | 国药准字H11020320 | 10ml:1g | Category A (甲) | XB05XAL208B002010100202 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20084492 | 10ml:1g | Category A (甲) | XB05XAL208B002010100239 | NHSA |
| 上海信谊金朱药业有限公司 | 国药准字H31021689 | 10ml:1g | Category A (甲) | XB05XAL208B002010100801 | NHSA |
| 津药和平(天津)制药有限公司 | 国药准字H12020518 | 10ml:1g | Category A (甲) | XB05XAL208B002010100874 | NHSA |
| 中国大冢制药有限公司 | 国药准字H20053710 | 10ml:1.0g | Category A (甲) | XB05XAL208B002010100967 | NHSA |
| 西南药业股份有限公司 | 国药准字H50020016 | 10ml:1g | Category A (甲) | XB05XAL208B002010100978 | NHSA |
| 辽宁民康制药有限公司 | 国药准字H20249307 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010101227 | NHSA |
| 常州兰陵制药有限公司 | 国药准字H32021915 | 10ml:1g | Category A (甲) | XB05XAL208B002010101376 | NHSA |
| 江苏大红鹰恒顺药业有限公司 | 国药准字H20163133 | 10ml:1g | Category A (甲) | XB05XAL208B002010101429 | NHSA |
| 济川药业集团有限公司 | 国药准字H32024784 | 10ml:1g | Category A (甲) | XB05XAL208B002010101453 | NHSA |
| 江苏正大丰海制药有限公司 | 国药准字H32025091 | 10ml:1g | Category A (甲) | XB05XAL208B002010101521 | NHSA |
| 江苏正大清江制药有限公司 | 国药准字H20163020 | 10ml:1g | Category A (甲) | XB05XAL208B002010101522 | NHSA |
| 江苏悦兴药业有限公司 | 国药准字H32024105 | 10ml:1g | Category A (甲) | XB05XAL208B002010101631 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H32022330 | 10ml:1g | Category A (甲) | XB05XAL208B002010101708 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32022139 | 10ml:1g | Category A (甲) | XB05XAL208B002010101723 | NHSA |
| 扬州中宝药业股份有限公司 | 国药准字H32024860 | 10ml:1g | Category A (甲) | XB05XAL208B002010101744 | NHSA |
| 武汉福星生物药业有限公司 | 国药准字H42022221 | 10ml:1g | Category A (甲) | XB05XAL208B002010101799 | NHSA |
| 湖北天圣药业有限公司 | 国药准字H42020421 | 10ml:1g | Category A (甲) | XB05XAL208B002010101842 | NHSA |
| 湖北津药药业股份有限公司 | 国药准字H20084467 | 10ml:1g | Category A (甲) | XB05XAL208B002010101866 | NHSA |
| 湖北科伦药业有限公司 | 国药准字H42021165 | 10ml:1g | Category A (甲) | XB05XAL208B002010101871 | NHSA |
| 武汉爱民制药股份有限公司 | 国药准字H42021611 | 10ml:1g | Category A (甲) | XB05XAL208B002010101924 | NHSA |
| 武汉久安药业有限公司 | 国药准字H42020907 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010101949 | NHSA |
| 海南倍特药业有限公司 | 国药准字H20247231 | 10ml: 1.5g | Category A (甲) | XB05XAL208B002010102013 | NHSA |
| 成都华宇制药有限公司 | 国药准字H20254317 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010102035 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H51021421 | 10ml:1g | Category A (甲) | XB05XAL208B002010102087 | NHSA |
| 榆林利君制药有限公司 | 国药准字H61022042 | 10ml:1g | Category A (甲) | XB05XAL208B002010102362 | NHSA |
| 陕西健民制药有限公司 | 国药准字H61023622 | 10ml:1g | Category A (甲) | XB05XAL208B002010102384 | NHSA |
| 吉林百年汉克制药有限公司 | 国药准字H20044214 | 10ml:1g | Category A (甲) | XB05XAL208B002010102416 | NHSA |
| 西安汤臣制药有限公司 | 国药准字H61020267 | 10ml∶1g | Category A (甲) | XB05XAL208B002010102434 | NHSA |
| 河北美图制药有限责任公司 | 国药准字H13022041 | 10ml:1g | Category A (甲) | XB05XAL208B002010102598 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13022128 | 10ml:1g | Category A (甲) | XB05XAL208B002010102662 | NHSA |
| 石家庄四药有限公司 | 国药准字H20183142 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010102763 | NHSA |
| 山西振东泰盛制药有限公司 | 国药准字H14022306 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010102946 | NHSA |
| 石药银湖制药有限公司 | 国药准字H14024049 | 10ml:1g | Category A (甲) | XB05XAL208B002010102964 | NHSA |
| 上海锦帝九州药业(安阳)有限公司 | 国药准字H41023037 | 10ml:1g | Category A (甲) | XB05XAL208B002010102994 | NHSA |
| 郑州卓峰制药有限公司 | 国药准字H41025290 | 10ml:1g | Category A (甲) | XB05XAL208B002010103013 | NHSA |
| 广东科泓药业有限公司 | 国药准字H20253560 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010103063 | NHSA |
| 河南省康华药业股份有限公司 | 国药准字H20053148 | 10ml:1g | Category A (甲) | XB05XAL208B002010103125 | NHSA |
| 上海浦津林州制药有限公司 | 国药准字H41022236 | 10ml:1g | Category A (甲) | XB05XAL208B002010103143 | NHSA |
| 上海现代哈森(商丘)药业有限公司 | 国药准字H20043780 | 10ml:1g | Category A (甲) | XB05XAL208B002010103202 | NHSA |
| 遂成药业股份有限公司 | 国药准字H41021043 | 10ml:1g | Category A (甲) | XB05XAL208B002010103204 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20013005 | 10ml:1g | Category A (甲) | XB05XAL208B002010103205 | NHSA |
| 新乡市常乐制药有限责任公司 | 国药准字H20184104 | 10ml:1g | Category A (甲) | XB05XAL208B002010103216 | NHSA |
| 中嘉生物科技(湖北省)有限公司 | 国药准字H20053971 | 10ml:1g | Category A (甲) | XB05XAL208B002010103377 | NHSA |
| 通化华夏药业有限责任公司 | 国药准字H22021380 | 10ml:1g | Category A (甲) | XB05XAL208B002010103556 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20084536 | 10ml:1g | Category A (甲) | XB05XAL208B002010103662 | NHSA |
| 黑龙江科朗制药有限公司 | 国药准字H20249675 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010103745 | NHSA |
| 重庆药谷制药有限公司 | 国药准字H20244355 | 20ml∶3.0g | Category A (甲) | XB05XAL208B002010103758 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H37021219 | 10ml:1g | Category A (甲) | XB05XAL208B002010103973 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20084490 | 10ml:1g | Category A (甲) | XB05XAL208B002010104098 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20173017 | 10ml:1g | Category A (甲) | XB05XAL208B002010104127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20153283 | 10ml:1g | Category A (甲) | XB05XAL208B002010104145 | NHSA |
| 山东益健药业有限公司 | 国药准字H20056057 | 10ml:1.0g | Category A (甲) | XB05XAL208B002010104192 | NHSA |
| 山东圣鲁制药有限公司 | 国药准字H37022261 | 10ml: 1g | Category A (甲) | XB05XAL208B002010104207 | NHSA |
| 安徽双鹤药业有限责任公司 | 国药准字H20258168 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010104346 | NHSA |
| 国药集团国瑞药业有限公司 | 国药准字H34023999 | 10ml:1g | Category A (甲) | XB05XAL208B002010104383 | NHSA |
| 杭州民生药业股份有限公司 | 国药准字H33021574 | 10ml:1g | Category A (甲) | XB05XAL208B002010104494 | NHSA |
| 浙江奥托康制药集团股份有限公司 | 国药准字H33020151 | 10ml:1g | Category A (甲) | XB05XAL208B002010104608 | NHSA |
| 浙江诚意药业股份有限公司 | 国药准字H33021426 | 10ml:1g | Category A (甲) | XB05XAL208B002010104615 | NHSA |
| 浙江泰康药业集团有限公司 | 国药准字H33021529 | 10ml:1g | Category A (甲) | XB05XAL208B002010104714 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20103057 | 10ml:1g | Category A (甲) | XB05XAL208B002010104718 | NHSA |
| 福建古田药业有限公司 | 国药准字H35020147 | 10ml:1g | Category A (甲) | XB05XAL208B002010104770 | NHSA |
| 湖南洞庭药业股份有限公司 | 国药准字H43020573 | 10ml:1g | Category A (甲) | XB05XAL208B002010104917 | NHSA |
| 湖南五洲通药业有限责任公司 | 国药准字H43020906 | 10ml:1g | Category A (甲) | XB05XAL208B002010104998 | NHSA |
| 湖南正清制药集团股份有限公司 | 国药准字H43020399 | 10ml:1g | Category A (甲) | XB05XAL208B002010105000 | NHSA |
| 贵州光正制药有限责任公司 | 国药准字H52020806 | 10ml:1g | Category A (甲) | XB05XAL208B002010105460 | NHSA |
| 昆明市宇斯药业有限责任公司 | 国药准字H53021542 | 10ml:1g | Category A (甲) | XB05XAL208B002010105604 | NHSA |
| 云南白药集团股份有限公司 | 国药准字H53020055 | 10ml:1g | Category A (甲) | XB05XAL208B002010105607 | NHSA |
| 山西诺成制药有限公司 | 国药准字H53020514 | 10ml:1g | Category A (甲) | XB05XAL208B002010105619 | NHSA |
| 甘肃兰药药业有限公司 | 国药准字H62020672 | 10ml:1g | Category A (甲) | XB05XAL208B002010105863 | NHSA |
| 酒泉大得利制药股份有限公司 | 国药准字H62020773 | 10ml:1g | Category A (甲) | XB05XAL208B002010105868 | NHSA |
| 国药集团新疆制药有限公司 | 国药准字H65020288 | 10ml:1g | Category A (甲) | XB05XAL208B002010106014 | NHSA |
| 湖北一半天制药有限公司 | 国药准字H20258217 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010106932 | NHSA |
| 华夏生生药业(北京)有限公司 | 国药准字H20253540 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010109910 | NHSA |
| 山西普恒制药有限公司 | 国药准字H20265613 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010181129 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20247092 | 20ml:3.0g | Category A (甲) | XB05XAL208B002010183083 | NHSA |
| 成都欣捷高新技术开发股份有限公司 | 国药准字H20249480 | 10ml∶1.5g | Category A (甲) | XB05XAL208B002010183325 | NHSA |
| 广州瑞尔医药科技有限公司 | 国药准字H20254516 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010183450 | NHSA |
| 南京恩泰医药科技有限公司 | 国药准字H20249553 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010183607 | NHSA |
| 广州艾奇西医药科技有限公司 | 国药准字H20243140 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010183795 | NHSA |
| 北京六环药业有限公司 | 国药准字H20253478 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010183878 | NHSA |
| 南京赛瑞谱顿制药有限公司 | 国药准字H20253715 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010183995 | NHSA |
| 信合援生制药股份有限公司 | 国药准字H20249638 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010184073 | NHSA |
| 海南紫程众投生物科技有限公司 | 国药准字H20243188 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010184112 | NHSA |
| 绪必迪药业(河北)有限公司 | 国药准字H20263803 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010184272 | NHSA |
| 福州基石医药科技有限公司 | 国药准字H20255870 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010184338 | NHSA |
| 江西博泰药业有限公司 | 国药准字H20255458 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010184580 | NHSA |
| 重庆万霖生物医药科技有限公司 | 国药准字H20254498 | 10ml: 1.5g | Category A (甲) | XB05XAL208B002010184896 | NHSA |
| 广州合和医药有限公司 | 国药准字H20254263 | 10ml︰1.5g | Category A (甲) | XB05XAL208B002010185013 | NHSA |
| 成都米子生物医药科技有限公司 | 国药准字H20249481 | 10ml∶1.5g | Category A (甲) | XB05XAL208B002010185135 | NHSA |
| 北京益民药业有限公司 | 国药准字H11020320 | 10ml:1g | Category A (甲) | XB05XAL208B002010200202 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20084492 | 10ml:1g | Category A (甲) | XB05XAL208B002010200239 | NHSA |
| 广东雷允上药业有限公司 | 国药准字H44022713 | 10ml:1g | Category A (甲) | XB05XAL208B002010200365 | NHSA |
| 上海信谊金朱药业有限公司 | 国药准字H31021689 | 10ml:1g | Category A (甲) | XB05XAL208B002010200801 | NHSA |
| 津药和平(天津)制药有限公司 | 国药准字H12020518 | 10ml:1g | Category A (甲) | XB05XAL208B002010200874 | NHSA |
| 中国大冢制药有限公司 | 国药准字H20053710 | 10ml:1.0g | Category A (甲) | XB05XAL208B002010200967 | NHSA |
| 西南药业股份有限公司 | 国药准字H50020016 | 10ml:1g | Category A (甲) | XB05XAL208B002010200978 | NHSA |
| 常州兰陵制药有限公司 | 国药准字H32021915 | 10ml:1g | Category A (甲) | XB05XAL208B002010201376 | NHSA |
| 江苏大红鹰恒顺药业有限公司 | 国药准字H20163133 | 10ml:1g | Category A (甲) | XB05XAL208B002010201429 | NHSA |
| 成都倍特药业股份有限公司 | 国药准字H32022330 | 10ml:1g | Category A (甲) | XB05XAL208B002010201708 | NHSA |
| 扬州中宝药业股份有限公司 | 国药准字H32024860 | 10ml:1g | Category A (甲) | XB05XAL208B002010201744 | NHSA |
| 武汉福星生物药业有限公司 | 国药准字H42022221 | 10ml:1g | Category A (甲) | XB05XAL208B002010201799 | NHSA |
| 湖北天圣药业有限公司 | 国药准字H42020421 | 10ml:1g | Category A (甲) | XB05XAL208B002010201842 | NHSA |
| 湖北津药药业股份有限公司 | 国药准字H20084467 | 10ml:1g | Category A (甲) | XB05XAL208B002010201866 | NHSA |
| 湖北科伦药业有限公司 | 国药准字H42021165 | 10ml:1g | Category A (甲) | XB05XAL208B002010201871 | NHSA |
| 武汉爱民制药股份有限公司 | 国药准字H42021611 | 10ml:1g | Category A (甲) | XB05XAL208B002010201924 | NHSA |
| 武汉久安药业有限公司 | 国药准字H42020907 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010201949 | NHSA |
| 海南倍特药业有限公司 | 国药准字H20247231 | 10ml: 1.5g | Category A (甲) | XB05XAL208B002010202013 | NHSA |
| 成都华宇制药有限公司 | 国药准字H20254317 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010202035 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H51021421 | 10ml:1g | Category A (甲) | XB05XAL208B002010202087 | NHSA |
| 榆林利君制药有限公司 | 国药准字H61022042 | 10ml:1g | Category A (甲) | XB05XAL208B002010202362 | NHSA |
| 吉林百年汉克制药有限公司 | 国药准字H20044214 | 10ml:1g | Category A (甲) | XB05XAL208B002010202416 | NHSA |
| 西安汤臣制药有限公司 | 国药准字H61020267 | 10ml∶1g | Category A (甲) | XB05XAL208B002010202434 | NHSA |
| 陕西顿斯制药有限公司 | 国药准字H61022495 | 10ml:1g | Category A (甲) | XB05XAL208B002010202503 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13022128 | 10ml:1g | Category A (甲) | XB05XAL208B002010202662 | NHSA |
| 石家庄四药有限公司 | 国药准字H20183142 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010202763 | NHSA |
| 山西振东泰盛制药有限公司 | 国药准字H14022306 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010202946 | NHSA |
| 石药银湖制药有限公司 | 国药准字H14024049 | 10ml:1g | Category A (甲) | XB05XAL208B002010202964 | NHSA |
| 上海锦帝九州药业(安阳)有限公司 | 国药准字H41023037 | 10ml:1g | Category A (甲) | XB05XAL208B002010202994 | NHSA |
| 郑州卓峰制药有限公司 | 国药准字H41025290 | 10ml:1g | Category A (甲) | XB05XAL208B002010203013 | NHSA |
| 广东科泓药业有限公司 | 国药准字H20253560 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010203063 | NHSA |
| 河南省康华药业股份有限公司 | 国药准字H20053148 | 10ml:1g | Category A (甲) | XB05XAL208B002010203125 | NHSA |
| 上海浦津林州制药有限公司 | 国药准字H41022236 | 10ml:1g | Category A (甲) | XB05XAL208B002010203143 | NHSA |
| 上海现代哈森(商丘)药业有限公司 | 国药准字H20043780 | 10ml:1g | Category A (甲) | XB05XAL208B002010203202 | NHSA |
| 新乡市常乐制药有限责任公司 | 国药准字H20184104 | 10ml:1g | Category A (甲) | XB05XAL208B002010203216 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20084536 | 10ml:1g | Category A (甲) | XB05XAL208B002010203662 | NHSA |
| 黑龙江科朗制药有限公司 | 国药准字H20249675 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010203745 | NHSA |
| 重庆药谷制药有限公司 | 国药准字H20244355 | 20ml∶3.0g | Category A (甲) | XB05XAL208B002010203758 | NHSA |
| 安徽双鹤药业有限责任公司 | 国药准字H20184043 | 10ml:1g | Category A (甲) | XB05XAL208B002010203951 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H37021219 | 10ml:1g | Category A (甲) | XB05XAL208B002010203973 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20084490 | 10ml:1g | Category A (甲) | XB05XAL208B002010204098 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20173017 | 10ml:1g | Category A (甲) | XB05XAL208B002010204127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20153283 | 10ml:1g | Category A (甲) | XB05XAL208B002010204145 | NHSA |
| 山东益健药业有限公司 | 国药准字H20056057 | 10ml:1.0g | Category A (甲) | XB05XAL208B002010204192 | NHSA |
| 山东圣鲁制药有限公司 | 国药准字H37022261 | 10ml: 1g | Category A (甲) | XB05XAL208B002010204207 | NHSA |
| 杭州民生药业股份有限公司 | 国药准字H33021574 | 10ml:1g | Category A (甲) | XB05XAL208B002010204494 | NHSA |
| 浙江泰康药业集团有限公司 | 国药准字H33021529 | 10ml:1g | Category A (甲) | XB05XAL208B002010204714 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20103057 | 10ml:1g | Category A (甲) | XB05XAL208B002010204718 | NHSA |
| 福建古田药业有限公司 | 国药准字H35020147 | 10ml:1g | Category A (甲) | XB05XAL208B002010204770 | NHSA |
| 昆明市宇斯药业有限责任公司 | 国药准字H53021542 | 10ml:1g | Category A (甲) | XB05XAL208B002010205604 | NHSA |
| 云南白药集团股份有限公司 | 国药准字H53020055 | 10ml:1g | Category A (甲) | XB05XAL208B002010205607 | NHSA |
| 山西诺成制药有限公司 | 国药准字H20173187 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010205619 | NHSA |
| 酒泉大得利制药股份有限公司 | 国药准字H62020773 | 10ml:1g | Category A (甲) | XB05XAL208B002010205868 | NHSA |
| 山西普恒制药有限公司 | 国药准字H20265613 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010281129 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20247092 | 20ml:3.0g | Category A (甲) | XB05XAL208B002010283083 | NHSA |
| 广州瑞尔医药科技有限公司 | 国药准字H20254516 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010283450 | NHSA |
| 广州艾奇西医药科技有限公司 | 国药准字H20243140 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010283795 | NHSA |
| 信合援生制药股份有限公司 | 国药准字H20249638 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010284073 | NHSA |
| 海南紫程众投生物科技有限公司 | 国药准字H20243188 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010284112 | NHSA |
| 广州合和医药有限公司 | 国药准字H20254263 | 10ml︰1.5g | Category A (甲) | XB05XAL208B002010285013 | NHSA |
| 成都米子生物医药科技有限公司 | 国药准字H20249481 | 10ml∶1.5g | Category A (甲) | XB05XAL208B002010285135 | NHSA |
| 广东雷允上药业有限公司 | 国药准字H44022713 | 10ml:1g | Category A (甲) | XB05XAL208B002010300365 | NHSA |
| 上海信谊金朱药业有限公司 | 国药准字H31021689 | 10ml:1g | Category A (甲) | XB05XAL208B002010300801 | NHSA |
| 中国大冢制药有限公司 | 国药准字H20053710 | 10ml:1.0g | Category A (甲) | XB05XAL208B002010300967 | NHSA |
| 江苏大红鹰恒顺药业有限公司 | 国药准字H20163133 | 10ml:1g | Category A (甲) | XB05XAL208B002010301429 | NHSA |
| 扬州中宝药业股份有限公司 | 国药准字H32024860 | 10ml:1g | Category A (甲) | XB05XAL208B002010301744 | NHSA |
| 湖北科伦药业有限公司 | 国药准字H42021165 | 10ml:1g | Category A (甲) | XB05XAL208B002010301871 | NHSA |
| 海南倍特药业有限公司 | 国药准字H20247231 | 10ml: 1.5g | Category A (甲) | XB05XAL208B002010302013 | NHSA |
| 陕西顿斯制药有限公司 | 国药准字H61022495 | 10ml:1g | Category A (甲) | XB05XAL208B002010302503 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13022128 | 10ml:1g | Category A (甲) | XB05XAL208B002010302662 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20084536 | 10ml:1g | Category A (甲) | XB05XAL208B002010303662 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20173017 | 10ml:1g | Category A (甲) | XB05XAL208B002010304127 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20103057 | 10ml:1g | Category A (甲) | XB05XAL208B002010304718 | NHSA |
| 扬州中宝药业股份有限公司 | 国药准字H20227042 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010381161 | NHSA |
| 海南紫程众投生物科技有限公司 | 国药准字H20243188 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010384112 | NHSA |
| 成都米子生物医药科技有限公司 | 国药准字H20249481 | 10ml∶1.5g | Category A (甲) | XB05XAL208B002010385135 | NHSA |
| 江苏大红鹰恒顺药业有限公司 | 国药准字H20163133 | 10ml:1g | Category A (甲) | XB05XAL208B002010401429 | NHSA |
| 陕西顿斯制药有限公司 | 国药准字H61022495 | 10ml:1g | Category A (甲) | XB05XAL208B002010402503 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H13022128 | 10ml:1g | Category A (甲) | XB05XAL208B002010402662 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20173017 | 10ml:1g | Category A (甲) | XB05XAL208B002010404127 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20103057 | 10ml:1g | Category A (甲) | XB05XAL208B002010404718 | NHSA |
| 扬州中宝药业股份有限公司 | 国药准字H20227042 | 10ml:1.5g | Category A (甲) | XB05XAL208B002010481161 | NHSA |
| 陕西顿斯制药有限公司 | 国药准字H61022495 | 10ml:1g | Category A (甲) | XB05XAL208B002010502503 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20173017 | 10ml:1g | Category A (甲) | XB05XAL208B002010504127 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20173017 | 10ml:1g | Category A (甲) | XB05XAL208B002010604127 | NHSA |
| 北京益民药业有限公司 | 国药准字H11020321 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020100202 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20084494 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020100239 | NHSA |
| 津药和平(天津)制药有限公司 | 国药准字H12020517 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020100874 | NHSA |
| 中国大冢制药有限公司 | 国药准字H20053711 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020100967 | NHSA |
| 江苏悦兴药业有限公司 | 国药准字H32024105 | 10ml:1g | Category A (甲) | XB05XAL208B002020101631 | NHSA |
| 江苏朗欧药业有限公司 | 国药准字H32022139 | 10ml:1g | Category A (甲) | XB05XAL208B002020101723 | NHSA |
| 扬州中宝药业股份有限公司 | 国药准字H32024860 | 10ml:1g | Category A (甲) | XB05XAL208B002020101744 | NHSA |
| 湖北津药药业股份有限公司 | 国药准字H20247289 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020101866 | NHSA |
| 湖北科伦药业有限公司 | 国药准字H42021164 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020101871 | NHSA |
| 武汉久安药业有限公司 | 国药准字H42020908 | 10ml:1g | Category A (甲) | XB05XAL208B002020101949 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H20247278 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020102087 | NHSA |
| 西安汤臣制药有限公司 | 国药准字H61020267 | 10ml∶1g | Category A (甲) | XB05XAL208B002020102434 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20184082 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020102662 | NHSA |
| 石家庄四药有限公司 | 国药准字H20183143 | 10ml:1g | Category A (甲) | XB05XAL208B002020102763 | NHSA |
| 石药银湖制药有限公司 | 国药准字H20227117 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020102964 | NHSA |
| 朗致集团万荣药业有限公司 | 国药准字H14020310 | 10ml:1g | Category A (甲) | XB05XAL208B002020102982 | NHSA |
| 广东科泓药业有限公司 | 国药准字H20253561 | 20ml:3g | Category A (甲) | XB05XAL208B002020103063 | NHSA |
| 上海浦津林州制药有限公司 | 国药准字H41022236 | 10ml:1g | Category A (甲) | XB05XAL208B002020103143 | NHSA |
| 裕松源药业有限公司 | 国药准字H41025693 | 10ml:1g | Category A (甲) | XB05XAL208B002020103163 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20013005 | 10ml:1g | Category A (甲) | XB05XAL208B002020103205 | NHSA |
| 新乡市常乐制药有限责任公司 | 国药准字H20269075 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020103216 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20084537 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020103662 | NHSA |
| 重庆药谷制药有限公司 | 国药准字H20244356 | 10ml∶1.5g | Category A (甲) | XB05XAL208B002020103758 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H20247294 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020103973 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20184029 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020104098 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20184024 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020104127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20153283 | 10ml:1g | Category A (甲) | XB05XAL208B002020104145 | NHSA |
| 杭州民生药业股份有限公司 | 国药准字H33021574 | 10ml:1g | Category A (甲) | XB05XAL208B002020104494 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20103056 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020104718 | NHSA |
| 山西诺成制药有限公司 | 国药准字H20173187 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020105619 | NHSA |
| 广州艾奇西医药科技有限公司 | 国药准字H20243139 | 20ml:3.0g | Category A (甲) | XB05XAL208B002020183795 | NHSA |
| 江西博泰药业有限公司 | 国药准字H20255459 | 20ml:3.0g | Category A (甲) | XB05XAL208B002020184580 | NHSA |
| 北京益民药业有限公司 | 国药准字H11020321 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020200202 | NHSA |
| 悦康药业集团股份有限公司 | 国药准字H20084494 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020200239 | NHSA |
| 津药和平(天津)制药有限公司 | 国药准字H12020517 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020200874 | NHSA |
| 江苏悦兴药业有限公司 | 国药准字H32024105 | 10ml:1g | Category A (甲) | XB05XAL208B002020201631 | NHSA |
| 湖北津药药业股份有限公司 | 国药准字H20247289 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020201866 | NHSA |
| 湖北科伦药业有限公司 | 国药准字H42021164 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020201871 | NHSA |
| 武汉久安药业有限公司 | 国药准字H42020908 | 10ml:1g | Category A (甲) | XB05XAL208B002020201949 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H20247278 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020202087 | NHSA |
| 西安汤臣制药有限公司 | 国药准字H61020267 | 10ml∶1g | Category A (甲) | XB05XAL208B002020202434 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20184082 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020202662 | NHSA |
| 石家庄四药有限公司 | 国药准字H20183143 | 10ml:1g | Category A (甲) | XB05XAL208B002020202763 | NHSA |
| 石药银湖制药有限公司 | 国药准字H20227117 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020202964 | NHSA |
| 广东科泓药业有限公司 | 国药准字H20253561 | 20ml:3g | Category A (甲) | XB05XAL208B002020203063 | NHSA |
| 上海浦津林州制药有限公司 | 国药准字H41022236 | 10ml:1g | Category A (甲) | XB05XAL208B002020203143 | NHSA |
| 裕松源药业有限公司 | 国药准字H41025693 | 10ml:1g | Category A (甲) | XB05XAL208B002020203163 | NHSA |
| 遂成药业股份有限公司 | 国药准字H41021043 | 10ml:1g | Category A (甲) | XB05XAL208B002020203204 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20013005 | 10ml:1g | Category A (甲) | XB05XAL208B002020203205 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20084537 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020203662 | NHSA |
| 重庆药谷制药有限公司 | 国药准字H20244356 | 10ml∶1.5g | Category A (甲) | XB05XAL208B002020203758 | NHSA |
| 华润双鹤利民药业(济南)有限公司 | 国药准字H20247294 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020203973 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20184029 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020204098 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20184024 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020204127 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20153283 | 10ml:1g | Category A (甲) | XB05XAL208B002020204145 | NHSA |
| 杭州民生药业股份有限公司 | 国药准字H33021574 | 10ml:1g | Category A (甲) | XB05XAL208B002020204494 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20103056 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020204718 | NHSA |
| 广州艾奇西医药科技有限公司 | 国药准字H20243139 | 20ml:3.0g | Category A (甲) | XB05XAL208B002020283795 | NHSA |
| 湖北科伦药业有限公司 | 国药准字H42021164 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020301871 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H20247278 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020302087 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20184082 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020302662 | NHSA |
| 上海浦津林州制药有限公司 | 国药准字H41022236 | 10ml:1g | Category A (甲) | XB05XAL208B002020303143 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20013005 | 10ml:1g | Category A (甲) | XB05XAL208B002020303205 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20084537 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020303662 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20184024 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020304127 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20103056 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020304718 | NHSA |
| 湖北科伦药业有限公司 | 国药准字H42021164 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020401871 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H20247278 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020402087 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20184082 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020402662 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20184024 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020404127 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20103056 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020404718 | NHSA |
| 四川美大康华康药业有限公司 | 国药准字H20247278 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020502087 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20184082 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020502662 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20184024 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020504127 | NHSA |
| 浙江天瑞药业有限公司 | 国药准字H20103056 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020504718 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20184082 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020602662 | NHSA |
| 辰欣药业股份有限公司 | 国药准字H20184024 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020604127 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20184082 | 10ml:1.5g | Category A (甲) | XB05XAL208B002020702662 | NHSA |
| 湖北科伦药业有限公司 | 国药准字H42021165 | 10ml:1g | Category A (甲) | XB05XAL208B002030101871 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20247130 | 20ml:3.0g | Category A (甲) | XB05XAL208B002030102662 | NHSA |
| 石家庄四药有限公司 | 国药准字H20247013 | 20ml: 3.0g | Category A (甲) | XB05XAL208B002030102763 | NHSA |
| 遂成药业股份有限公司 | 国药准字H20247305 | 10ml:1.5g | Category A (甲) | XB05XAL208B002030103204 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20217128 | 10ml:1.5g | Category A (甲) | XB05XAL208B002030103205 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20247081 | 20ml:3.0g | Category A (甲) | XB05XAL208B002030103662 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20084490 | 10ml:1g | Category A (甲) | XB05XAL208B002030104098 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20237084 | 10ml:1.5g | Category A (甲) | XB05XAL208B002030104145 | NHSA |
| 山西诺成制药有限公司 | 国药准字H53020514 | 10ml:1g | Category A (甲) | XB05XAL208B002030105619 | NHSA |
| 中国大冢制药有限公司 | 国药准字H20053711 | 10ml:1.5g | Category A (甲) | XB05XAL208B002030200967 | NHSA |
| 湖北科伦药业有限公司 | 国药准字H42021164 | 10ml:1.5g | Category A (甲) | XB05XAL208B002030201871 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20247130 | 20ml:3.0g | Category A (甲) | XB05XAL208B002030202662 | NHSA |
| 石家庄四药有限公司 | 国药准字H20247013 | 20ml: 3.0g | Category A (甲) | XB05XAL208B002030202763 | NHSA |
| 遂成药业股份有限公司 | 国药准字H20247305 | 10ml:1.5g | Category A (甲) | XB05XAL208B002030203204 | NHSA |
| 国药集团容生制药有限公司 | 国药准字H20217128 | 10ml:1.5g | Category A (甲) | XB05XAL208B002030203205 | NHSA |
| 哈尔滨三联药业股份有限公司 | 国药准字H20247081 | 20ml:3.0g | Category A (甲) | XB05XAL208B002030203662 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20237084 | 10ml:1.5g | Category A (甲) | XB05XAL208B002030204145 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20247130 | 20ml:3.0g | Category A (甲) | XB05XAL208B002030302662 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20237084 | 10ml:1.5g | Category A (甲) | XB05XAL208B002030304145 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20247130 | 20ml:3.0g | Category A (甲) | XB05XAL208B002030402662 | NHSA |
| 山东齐都药业有限公司 | 国药准字H20237084 | 10ml:1.5g | Category A (甲) | XB05XAL208B002030404145 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20247130 | 20ml:3.0g | Category A (甲) | XB05XAL208B002030502662 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20247130 | 20ml:3.0g | Category A (甲) | XB05XAL208B002030602662 | NHSA |
| 河北天成药业股份有限公司 | 国药准字H20247130 | 20ml:3.0g | Category A (甲) | XB05XAL208B002030702662 | NHSA |
| 中国大冢制药有限公司 | 国药准字H20053710 | 10ml:1.0g | Category A (甲) | XB05XAL208B002040100967 | NHSA |
| 遂成药业股份有限公司 | 国药准字H20247306 | 20ml:3.0g | Category A (甲) | XB05XAL208B002040103204 | NHSA |
| 山东华鲁制药有限公司 | 国药准字H20084490 | 10ml:1g | Category A (甲) | XB05XAL208B002040104098 | NHSA |
| 遂成药业股份有限公司 | 国药准字H20247306 | 20ml:3.0g | Category A (甲) | XB05XAL208B002040203204 | NHSA |
Approval numbers and companies are deduplicated separately; packaging records remain individually listed. An empty insurance class means it is unstated. NHSA codes supply no approval date and do not establish the outcome of an acceptance number.
Current under-review applications
Loaded records: 10 filings and 9 distinct first applicants.
Generic 5 · Supplement 5
| Company / applicant | Acceptance number | Application type | Accepted | Strength / specification | View source |
|---|---|---|---|---|---|
| 济南康桥医药科技有限公司;西安利君康乐制药有限责任公司 | CYHS2601732 | Generic | 2026/07/20 | Not stated by source | CDE |
| 浙江天瑞药业有限公司 | CYHB2650138 | Supplement | 2026/06/17 | Not stated by source | CDE |
| 湖北津药药业股份有限公司;津药和平（天津）制药有限公司 | CYHB2601034 | Supplement | 2026/06/01 | Not stated by source | CDE |
| 湖北津药药业股份有限公司;津药和平（天津）制药有限公司 | CYHB2601033 | Supplement | 2026/06/01 | Not stated by source | CDE |
| 华润双鹤利民药业（济南）有限公司 | CYHB2502558 | Supplement | 2025/12/22 | Not stated by source | CDE |
| 山西诺成制药有限公司 | CYHS2504290 | Generic | 2025/12/16 | Not stated by source | CDE |
| 上海浦津林州制药有限公司 | CYHB2550303 | Supplement | 2025/08/27 | Not stated by source | CDE |
| 山东新华制药股份有限公司;广东星昊药业有限公司 | CYHS2503088 | Generic | 2025/08/23 | Not stated by source | CDE |
| 西安京西双鹤药业有限公司 | CYHS2503058 | Generic | 2025/08/20 | Not stated by source | CDE |
| 浙江国镜药业有限公司 | CYHS2602728 | Generic | 2026/11/06 | Not stated by source | CDE |
New generic filings in 2026
Loaded records: 2 filings and 2 distinct first applicants.
API registrations
Non-component matches: 13 companies with A status and 5 I-status records. Component matches are listed separately and excluded from these counts.
| Name | Company / applicant | Registration number | Status | Name match | Source update date | View source |
|---|---|---|---|---|---|---|
| 氯化钾 | 湖南浩森制药有限公司 | Y20260000475 | I | Exact ingredient | 2026/06/09 | CDE |
| 氯化钾 | 湖南新绿方药业有限公司 | Y20240001312 | I | Exact ingredient | 2025/02/07 | CDE |
| 氯化钾 | 河南普瑞制药有限公司 | Y20200001526 | A | Exact ingredient | 2026/01/01 | CDE |
| 氯化钾 | Chemtrade Solutions LLC | Y20210000064 | I | Exact ingredient | 2021/02/03 | CDE |
| 氯化钾 | K+S Minerals and Agriculture GmbH | Y20200001313 | A | Exact ingredient | 2023/02/22 | CDE |
| 氯化钾 | 天津海光科技发展股份有限公司 | Y20190009650 | A | Exact ingredient | 2025/05/14 | CDE |
| 氯化钾 | 江苏省勤奋药业有限公司 | Y20190009523 | A | Exact ingredient | 2025/05/24 | CDE |
| 氯化钾 | 自贡鸿鹤制药有限责任公司 | Y20190009377 | A | Exact ingredient | 2025/03/29 | CDE |
| 氯化钾 | 河北华晨药业集团有限公司 | Y20190008767 | A | Exact ingredient | 2025/08/16 | CDE |
| 氯化钾 | 台山市新宁制药有限公司 | Y20190008432 | A | Exact ingredient | 2026/04/03 | CDE |
| 氯化钾 | 西安利君精华药业有限责任公司 | Y20190005465 | A | Exact ingredient | 2025/11/21 | CDE |
| 氯化钾 | 云南大唐汉方制药有限公司 | Y20190005363 | A | Exact ingredient | — | CDE |
| 氯化钾 | 吉林省西点药业科技发展股份有限公司 | Y20190003452 | A | Exact ingredient | 2025/09/18 | CDE |
| 氯化钾 | 北京市燕京药业有限公司 | Y20190002514 | A | Exact ingredient | 2026/02/04 | CDE |
| 氯化钾 | 重庆新大新药业股份有限公司 | Y20190001967 | A | Exact ingredient | 2026/05/20 | CDE |
| 氯化钾 | 自贡鸿鹤制药有限责任公司 | Y20180000646 | A | Exact ingredient | 2019/01/18 | CDE |
| 氯化钾 | Dead Sea Works Ltd. | Y20180001476 | A | Exact ingredient | 2026/04/21 | CDE |
| 氯化钾 | 天津海光药业股份有限公司 | Y20180000599 | I | Exact ingredient | 2018/12/17 | CDE |
| 氯化钾 | 江苏省勤奋药业有限公司 | Y20180000044 | I | Exact ingredient | — | CDE |
A/I are source statuses. Matching uses exact ingredients, salt-normalized names and maintained combination components, without fuzzy matching. A-status companies are deduplicated by the first registered company. Components are excluded from headline counts; the register does not identify the associated formulation.
What changed recently?
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately.
Trial registration does not mean an application will follow.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
NHSA edition maintained to 2026-10-23; latest successful catalogue check: 2026/11/10 07:23. NHSA records lack approval dates; only an earlier edition or observation establishes precedence.
-
2026/11/06Accepted
-
2026/10/29No longer listed under review
河北天成药业股份有限公司
CYHS2502703
Fact date: 2026/10/29 · Site observation date: 2026/10/29
Accepted: 2025/07/28
not on the CDE under-review list in this snapshot; the review / approval outcome is to be checked
View source ↗ -
2026/10/20Marketing application approved
河南普瑞药业有限公司
CYHS2404518 · 国药准字H20266300
Fact date: 2026/10/20 · Publication date: 2026/10/22 · Site observation date: 2026/11/03
The loaded NHSA codes and chemical-drug catalogue contain no evidence confirming an earlier same-name approval for this company. This does not establish the absence of an earlier approval.
View source · Table row 14 ↗ -
2026/08/14Accepted
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/10 07:27
- Chemical-drug catalogue
- Last successful update: 2026/11/10 07:23
Distinct full holder names; manufacturers are used only where the holder is unstated. The catalogue covers only part of the chemical-drug market. Categories are counted as recorded, not as a complete market census.
- Full API register
- Last successful update: 2026/11/10 07:25
- NHSA drug codes
- Last successful update: 2026/11/05 06:45
The fully loaded edition was maintained to 2026-10-23. Publication lags maintenance: the verified 2026-10-16 edition was published on 10-28, a 12-day gap. This is not a fixed lag for every edition.
- NMPA drug delivery notices
- Last successful update: 2026/11/10 18:31
First index-page publication dates: 2026-10-26 to 2026-11-10; 0 pages pending. Covers loaded notices only, not a complete historical approval database.
- Drug Clinical Trial Registry and Information Disclosure Platform
- Last successful update: 2026/11/10 08:10 · Current coverage may be incomplete
Daily collection reads new registrations. Backfill covers registration numbers from 2025 onward (CTR2025/CTR2026), not first-publication years. States are dated observations; revisions are not tracked.
This product is outside the trial-registration backfill scope. New registrations after daily collection started remain in scope. Historical rows may also be found by another product search; neither implies complete historical coverage for this product.
Public-product searches scanned: 3/30; discovered pending details: 20. Record counts in unscanned portions remain unknown.
Filings are counted by acceptance number and filing companies by first applicant. Strengths may have separate applications. Drug names are normalized only for width and whitespace; distinct generic names, dosage forms and combinations remain separate. Unstated strengths are marked. Company counts from different sources must not be added together.
Fact dates are approval dates, acceptance dates, trial first-publication dates or complete-snapshot observation dates, as applicable. Publication and site-observation dates are separate. Historical backfills are not current-period new events. Exit records cover currently inactive applications with an identifiable complete snapshot, not a full review history.
Free follow
Follow changes to Potassium Chloride Injection
Up to 3 drugs per email address, in one weekly digest. Starts after email confirmation; unsubscribe at any time.
Subscriptions
Next-day facts and deliverable timelines
- One email the next day when new facts are collected for your followed products.
- Export the complete loaded event timeline for each followed product as CSV.
- Add up to 4 additional recipients, each confirmed by email.
- Increase your follow limit from 3 to 10 products.
Quarterly
US$540
Billed every three months
US$180 per month
Yearly
US$1,920
Billed every year
US$160 per month
Online subscriptions are not enabled. The form below registers interest; it does not charge or activate access.
Separate one-time purchase
US Orange Book × China records comparison
Full table and CSV export for 12 months from payment, with monthly data updates. No automatic renewal.
Subscriptions and comparison-table access are purchased separately. Neither includes the other.
US$490
One payment · 12 months of access
Online comparison-table purchase is not enabled.
Billed by Creem, our merchant of record · Terms · Refund policy